Sir,

Autoantibody-mediated encephalitis (AME) is a neurological illness caused by autoantibodies of autoimmune or paraneoplastic pathology, directed against the neuronal surface, synaptic antigens, or the intracellular proteins.\[[@ref1]\] The onset is subacute, with the occurrence of altered mental status, seizures, and cognitive deficits, with a rapid progression. AME has been classified in different ways, including those based on anatomical sites involved or the underlying etiology, or eponymously classification too is present.\[[@ref2]\] One such terminology is limbic encephalitis (LE), where autoimmune or paraneoplastic affection of the limbic system is implicated as the etiology. LE can manifest with diverse psychopathology, including delusions, hallucinations, irritability, aggression, anxiety, depression, and catatonic symptoms.\[[@ref1][@ref2][@ref3]\] LE can also have atypical etiologies including nonparaneoplastic and seronegative varieties, especially during the early course of illness.\[[@ref2]\] Psychiatric presentations of atypical variants of LE are not reported in the existing literature.

We present a case of acute seronegative nonparaneoplastic LE with complex neurological and psychiatric symptomatology including obsessions. The diagnostic implications of the clinical presentation and the integrated neuropsychiatric management required are also discussed.

CASE REPORT {#sec1-1}
===========

A 28-year-old woman presented to the emergency department with multiple episodes of seizures, preceded by high-grade fever and headache for 10 days. There was no history of vomiting, blurred vision, or neck stiffness suggestive of meningeal irritation. The epileptic attacks started as right-sided focal seizures followed by generalized tonic--clonic seizures. The episodes were multiple, with a frequency of one episode every 2--3 h, with acute onset and offset; lasting 3--5 min; and associated with loss of consciousness, loss of posture, and postictal drowsiness. Her medical history revealed the presence of hypothyroidism. There was no history of rheumatic or chronic inflammatory conditions. There was no family history of significant medical or psychiatric illness. She developed refractory status epilepticus, which responded to a cocktail of phenytoin 300 mg/day, carbamazepine 600 mg/day, valproate 1500 mg/day, levetiracetam 3 g/day, clobazam 20 mg/day, and midazolam infusion. She was also prescribed prednisolone (50 mg/day) and acyclovir (500 mg/day) for 1 week as prophylactic medications for AME and probable viral encephalitis. The patient required intensive care unit (ICU) monitoring for 3 weeks for adequate control of seizures. Her blood biochemistry evaluation for autoimmune disorders returned normal \[[Table 1](#T1){ref-type="table"}\]. The electroencephalogram (EEG) revealed fast beta background activity with an abnormal slowing in the left-sided leads with bilateral infrequent inter-ictal epileptiform discharges. Computerized tomography (CT) of the brain revealed bilateral medial temporal lobe hyperintensities. The CT of the thorax and abdomen was taken to rule out paraneoplastic syndrome, which returned normal. Acute onset of seizure disorder, status epilepticus, lack of focal neurological deficits, and the involvement of temporal lobes pointed to a clinical diagnosis of LE.

###### 

Blood biochemistry, serology, drug levels, and autoimmune panel results

  Parameter                                             Patient value                        Normal range
  ----------------------------------------------------- ------------------------------------ ---------------------
  Hemoglobin                                            12.6                                 11.7-15.5 gm/dL
  White blood cell count                                7.35                                 4.0-11.0 × 10^3^/µL
  Sodium                                                139.8                                136-146 mEq/L
  Potassium                                             3.42                                 3.5-5.5 mEq/L
  Blood urea                                            10                                   15-40 mg/dL
  Serum creatinine                                      0.72                                 0.5-0.9 mg/dL
  Liver function tests                                                                       
   Total Bilirubin                                      0.24                                 0.3-1.3 mg/dL
   Direct Bilirubin                                     0.15                                 0.1-0.4 mg/dL
   Serum Protein                                        6.3                                  6.7-8.6 g/dL
   Serum Albumin                                        3.9                                  3.5-5.5 g/dL
   AST                                                  28                                   12-38 IU/L
   ALT                                                  26                                   7-41 IU/L
   ALP                                                  99                                   108-306 IU/L
  Thyroid function tests                                                                     
   Free T3                                              2.1                                  2.1-4.4 pg/ml
   Free T4                                              0.95                                 0.8-2.7 ng/dL
   TSH                                                  1.44                                 0.35-5.5 µIU/ml
   Random blood sugar                                   108                                  75-140 mg/dL
  Blood culture                                         Sterile after 2 days of incubation   
  Serology                                                                                   
   HIV                                                  Negative                             
   HbsAg                                                Negative                             
   anti-HCV                                             Nonreactive                          
   VDRL                                                 Nonreactive                          
   Dengue (IgM ELISA, NS1)                              Negative                             
   Malaria (ICT Pf and Peripheral smear)                Negative                             
   PCR for Japanese encephalitis                        Negative                             
  CSF analyses                                                                               
   Cell count                                           10 cells (8 lymphocytes)             
   Glucose                                              69                                   75-140 mg/dL
   Chloride                                             123.4                                102-109 mEq/L
   Protein                                              30                                   15-50 mg/dL
   Culture                                              Sterile                              
   HSV PCR                                              Negative                             
   Oligoclonal bands                                    Negative                             
  Autoimmune panel                                                                           
   Anti-TPO                                             40.3                                 0-35 IU/ml
   Anti-TG                                              \<15                                 0-40 IU/ml
   ANA                                                  Negative                             
   CSF autoimmune panel (done twice for confirmation)                                        
   GABA-B                                                                                    
   AMPA 1                                               Negative                             
   AMPA 2                                                                                    
   NMDAR                                                                                     
   VGKC                                                                                      
  Drug levels                                                                                
   Valproate                                            62                                   50-100 µg/ml
   Carabamazepine                                       6                                    4-12 mg/L

μIU -- micro International Units, μg -- microgram, μL -- microliter, ALP -- Alkaline phosphatase, ALT -- Alanine transaminase, AMPA - α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, ANA -- Antinuclear antibody, Anti -- TG -- Antithyroglobulin antibody, Anti-TPO -- Antithyroid peroxidase antibody, Anti-HCV -- Anti-hepatitis C virus antibody, AST -- Aspartate transaminase, CSF -- Cerebrospinal fluid, dL -- deciliter, ELISA - Enzyme-linked immune sorbent assay, GABA-B -- gamma-aminobutyric acid -- B, g -- gram, HbsAg -- Hepatitis B surface antigen, HIV -- Human immunodeficiency virus, HSV -- Herpes simplex virus, ICT Pf -- Immunochromatographic test for *Plasmodium falciparum*, IgM -- Immunoglobulin M, IU -- International units, L -- liter, mEq -- milliequivalent, mg -- milligram, ml -- milliliter, ng -- nanogram, NMDAR - N-methyl-d-aspartate receptor, NS1 -- Dengue nonstructural protein 1, PCR -- polymerase chain reaction, pg -- picogram, T3 -- triiodothyronine, T4 -- thyroxine, TSH -- Thyroid stimulating hormone, VDRL -- Venereal Disease Research Laboratory, VGKC -- Voltage-gated potassium channel

During the ICU stay, the patient developed postictal psychosis characterized by episodes of irritability, mutism, staring, posturing, and auditory hallucinations. There were no signs of delirium. The postictal psychosis improved with quetiapine (50 mg/day) in a week\'s time. After discharge, over 3 months' period, she had low mood, anhedonia, ideas of worthlessness and hopelessness, and suicidal tendencies. She had repetitive and unexplained emotional outbursts. On detailed exploration, she revealed that she experienced repetitive and intrusive urges to have physical intimacy with her spouse. Though she recognized those urges to be her own, repetitive, and intrusive, she could not reveal further information such as irrationality, control, or any associated anxiety. She did not reveal any mental or motor compulsions. The mental status examination revealed depressed affect, the presence of obsessive urges of sexual content, and defects in recent memory, and visuospatial functioning, with intact executive functions, praxis, and language functions. The patient was diagnosed to have Organic Depressive Disorder (F06.32) as per the International Classification of Diseases-10^th^ edition (ICD-10).\[[@ref4]\] Antipsychotics were stopped, and she was started on fluoxetine (20--40 mg/day) and clonazepam (0.75 mg/day). Her mood symptoms, obsessive thoughts, and distress improved significantly in a month\'s time \[[Table 2](#T2){ref-type="table"}\]. The patient was followed up for 3 months with no further relapses. Informed consent was obtained for patient management and write up of this report.

###### 

Scores on rating scales

  Scale     Baseline     After 4 weeks of antidepressant therapy                                      
  --------- ------------ ----------------------------------------- ------- ------------ ------------- -------
  HDRS-17   21           7                                                                            
  Y-BOCS    Obsessions   Compulsions                               Total   Obsessions   Compulsions   Total
  14        4            18                                        5       1            6             
  MMSE      27           27                                                                           

HDRS-17 -- Hamilton depression rating scale -- 17 items, MMSE -- Mini mental state examination, Y-BOCS -- Yale Brown Obsessive complusive scale

DISCUSSION {#sec1-2}
==========

The above clinical scenario sheds light on the diagnostic process of atypical LE and the complex neurological and psychiatric presentations associated with atypical variants of LE. A systematic evaluation of LE can be performed along the lines of clinical assessment, autoimmune panel, EEG, and neuroimaging investigations.\[[@ref5][@ref6]\]

In our patient, the clinical presentation was characterized by fever prodrome; generalized seizures with rapid progression to status epilepticus; seizure refractoriness; and polymorphic psychiatric presentation, including signs of catatonia, auditory hallucinations, depressive symptoms, and obsessional urges. The prevailing literature supports that the presence of a febrile prodrome, seizures, abrupt and polymorphic psychiatric complaints, rapid illness progression, poor treatment response, memory disturbances, and focal neurological signs should rouse the possibility of autoimmune encephalitis in patients with acute psychiatric disturbances.\[[@ref5][@ref6][@ref7]\] Our case highlights that, apart from various psychiatric complaints, obsessional urges, which lack the classical features of irrationality or compulsive behaviors, can occur in patients with LE.\[[@ref2][@ref3][@ref8]\] The occurrence of obsessions and depressive symptoms can be due to the involvement of medial temporal lobes, which are implicated in both seizures and emotional regulation.\[[@ref9]\]

The investigations for infectious, metabolic, endocrine, and drug-induced causes returned normal, ruling out common causes for encephalitis \[[Table 1](#T1){ref-type="table"}\]. Further, normal autoimmune panel eliminated common autoimmune causes for LE. Recent literature reports that rarely LE can be nonparaneoplastic and that LE can be seronegative during the early stages.\[[@ref1][@ref2][@ref3]\] Similar to what was observed in our patient, focal or diffuse slowing and epileptiform discharges in the EEG and bilateral medial lobe hyperintensities based on neuroimaging are consistently associated with LE.\[[@ref6][@ref7]\]

The comprehensive pharmacotherapy of the patient comprised high-dose corticosteroids, antiepileptics, and various psychotropics. Complex psychiatric disturbances in LE shall entail the supplementation of mood stabilizing antiepileptics to control agitation, atypical antipsychotics for psychosis, and antianxiety agents.\[[@ref5][@ref7]\]

The limitations of our report are that autoantibodies such as Glutamic Acid Decarboxylase 65 (GAD65) and those against Gamma-aminobutyric acid--A (GABA-A) receptor were not studied as their kits were not available. Rare possibilities such as new-onset refractory status epilepticus (NORSE), febrile infection related epilepsy syndrome (FIRES), or prion diseases were not actively considered.

Nevertheless, the present report adds to the literature that LE can be atypical when it presents in nonparaneoplastic and seronegative forms. In such atypical LE, the neurological and psychiatric symptoms can be more variegated than LE with an identified etiology. A careful assessment of the clinical presentation invariably determines the appropriate diagnostic work-up of the LE patient. An early, thorough, and integrated neuropsychiatric approach will be able to overcome the difficulties in such cases. Future studies are necessary to understand the symptoms of atypical LE in greater detail, identify their etiopathogenesis, and provide scope for the effective management of its myriad neuropsychiatric manifestations.
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